The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 966 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 1,400 | 7,075 | SH | SOLE | 7,075 | 0 | 0 | ||
BAUSCH HEALTH COS INC | COM | 071734107 | 422 | 16,750 | SH | SOLE | 16,750 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 539 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 3,886 | 20,133 | SH | SOLE | 20,133 | 0 | 0 | ||
GENERAL ELECTRIC CO | COM | 369604103 | 8,243 | 785,000 | SH | SOLE | 785,000 | 0 | 0 | ||
GENETIC TECHNOLOGIES LTD | SPONSORED ADR | 37185R208 | 17 | 28,437 | SH | SOLE | 28,437 | 0 | 0 | ||
ISHARES TR | MSCI EAFE ETF | 464287465 | 1,036 | 15,764 | SH | SOLE | 15,764 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 3,884 | 24,979 | SH | SOLE | 24,979 | 0 | 0 | ||
NEPTUNE WELLNESS SOLUTIONS I | COM | 64079L105 | 413 | 94,993 | SH | SOLE | 94,993 | 0 | 0 | ||
SPDR S AND P 500 ETF TR | TR UNIT | 78462F103 | 5,377 | 18,350 | SH | SOLE | 18,350 | 0 | 0 | ||
SELECT SECTOR SPDR TR | SBI INT-FINL | 81369Y605 | 2,855 | 103,430 | SH | SOLE | 103,430 | 0 | 0 | ||
SELECT SECTOR SPDR TR | RL EST SEL SEC | 81369Y860 | 528 | 14,366 | SH | SOLE | 14,366 | 0 | 0 | ||
VANGUARD INTL EQUITY INDEX F | FTSE EUROPE ETF | 922042874 | 342 | 6,227 | SH | SOLE | 6,227 | 0 | 0 | ||
YETI HLDGS INC | COM | 98585X104 | 1,853 | 64,000 | SH | SOLE | 64,000 | 0 | 0 |